Tadvalkar Laura 4
4 · Cidara Therapeutics, Inc. · Filed Jul 19, 2024
Insider Transaction Report
Form 4
Tadvalkar Laura
Director
Transactions
- Award
Stock Option (right to buy)
2024-07-18+2,125→ 2,125 totalExercise: $12.64Exp: 2034-07-17→ Common Stock (2,125 underlying)
Footnotes (2)
- [F1]The shares subject to the option shall vest on the earlier of (i) the first anniversary of the date of grant or (ii) the day prior to the date of the Issuer's 2025 annual meeting of stockholders.
- [F2]Under the Reporting Person's arrangement with RA Capital Management, L.P. (the "Adviser"), the Reporting Person holds the option for the benefit of the RA Capital Healthcare Fund, L.P. (the "Fund"). The Reporting Person is obligated to turn over to the Adviser any net cash or stock received upon exercise of the stock option, which will offset advisory fees owed by the Fund to the Adviser. The Reporting Person therefore disclaims beneficial ownership of the option and underlying common stock.